4
Changes in Ownership
CNS Pharmaceuticals, Inc. Filed Acc 0001683168-23-002830
Chief Executive Officer acquired 1,250 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
Climaco John M · Chief Executive Officer
Table I: Non-derivative
1 line| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2023-04-28 | Exercise or conversion : show line 1 in the form | +1,250 | 46,260 | D |
Table II: Derivative
1 line| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2023-04-28 | Exercise or conversion : show line 2 in the form Restricted Stock Units | −1,250 | 60,201 | D |
Loading xslF345X04/ownership.xml…